We are

Experts in Patient Engagement and Access

Read more
About admedicum – Patient Driven Solutions

The admedicum team combines an adept understanding of the nuances of working with both patient groups and industry from years of practical experience.

Our special expertise is to merge patient benefits and corporate success in a variety of project types while planning for and achieving measurable results. We strive for credibility, genuine cooperation, and sustainable benefit for everyone.

As a leading patient engagement network in Europe, we are driven by the common good and always ensure transparency, independence of all partners, and respect for human dignity.


Podcast button

Patients on the Move”  – now available on Spotify.

Nothing about us without us! We always work with patients!

our solutions

What we do

A small selection of our services, to give you an idea. Read more in the case studies.

Patient engagement

  • Internal Patient Engagement Roadmap Workshop
  • Mapping the Patient Landscape
  • Understanding the Patient Pathway
  • Developing a Patient Advisory Board
  • Improving patient information and community building
  • Patient Relevance Review
  • Patient Readiness & Patient Engagement Management
  • Patient Insights, Structured Patient Dialogue and Patient Co-Creation
  • Patient Advocacy Liaison

Read patient engagement case studies

Patient Access

  • Patient-focused product & service development
  • Stakeholder Engagement
  • Pricing & Reimbursement
  • Supporting Patient Access to Treatment
  • Multi-Stakeholder Co-Creation Session on RWE
  • Co-creating a Patient Support Program

Read patient access case studies

drug development

  • Co-Creating Clinical Trial Design and Recruitment Strategy
  • patient2site: Enhancing Clinical Trial Recruitment

Read more about our approach to clinical trials

digital solutions

  • Including patients at a very early stage in the development and design of digital solutions, services, or Digital Therapeutics (DTx)
  • Obtaining patient insights to make sure that digital offerings really matter and are aligned with patients’ needs
  • Using our full suite of patient engagement services to ensure patient co-development of digital services & solutions
  • Helping healthcare stakeholders to build digital and DTx offerings by connecting their business with digital technology and patients’ needs
  • patient2care® – our digital guide for patients with rare and complex diseases
Our values

What we stand for

1We create societal value, by

Working with patients, for the benefit of patients

Creating real, measurable value for patient communities

Transforming the health care system to be more patient-centric

Advocating for patient interests in the development of services and products

2We create benefits and value for our clients, through

Services tailored to the unique needs of our clients

High methodological quality

Scientifically based deliverables that are accepted by both the public and compliance departments

3Our core values

Reliable, credible, trustworthy, transparent, honest

Passionate - driven to involve patients

Innovative / bold - our vision to make patient engagement “business as usual” in drug development

Respect and fairness towards all stakeholders

Feedback from our Clients and Partners


"I clearly recommend admedicum’s services"

“We embraced admedicum’s services, in collaboration with Trials24, only by the time that we became aware that the inclusion of patients with certain hematologic malignancies in an ongoing phase I study of a PRAME-specific TCR-T was not as expected due to the very restrictive nature of the eligibility criteria. The admedicum team’s experience and creativity towards a fruitful approach to our reality of clinical study conduct within Germany clearly translated in a gateway towards potentially eligible patients, whom, upon a triage, could ultimately be guided in contacting the investigational sites. In concerto, a dedicated website for the specific conditions, use of advertising on social media and local radio presentation by clinical experts and the principal investigator did land a high number of patients or their caregivers to undergo the initial web-based triage towards an improved patient recruitment. Hence I clearly recommend admedicum’s services for clinical studies for which patient recruitment is expected to be difficult, ideally well before the start of the study.”

René Goedkoop MD,
Acting Chief Medical Officer, Medigene AG
"Many thanks to all of you for the great elaboration"
“Many thanks to all of you for the great elaboration of the project and the extensive exchange. I am still impressed that after the initial long questionnaire, which we worked out together over and over again, such a great final result was achieved and that this was only possible because many patients concerned had the opportunity to actively participate in the survey/discussion.”
Sabine Wagner,
Board member and regional group leader Network Neuroendocrine Tumors (NeT) e.V.
"Philipp's passion for patients needs is as admirable"

Philipp’s passion for patients’ needs and real innovation is as admirable as is his sharp intellect and his understanding of the science, providing for a blend of capabilities and attitude that make “business” equally enjoyable for colleagues and business partners. One always feels his determination to succeed, paired with the patience that our business needs, the preparedness and energy to deal with foreseeable and non-foreseeable hurdles keeping the motivation high at all times as a contributor to a project and as a leader.

Philipp’s vision of a patient centric approach to pharmaceutical development, in particular in rare and orphan diseases, together with the implementation of a concrete series of patient focused events has created a momentum that our company is still benefitting from.

Steffen Sturzebecher,
SVP head of innovation Unit Specialty Therapeutics, Grunenthal
"How much he cared about all people living with rare diseases is underpinned by his volunteer work"

“During his time as CEO of Mukoviszidose e.V., the German Cystic Fibrosis (CF) Association (2002 – 2014) and Managing Director of our research affiliate, Mukoviszidose Institut GmbH (2006 – 2015), I got to appreciate Andreas Reimann. I am a father of a son living with CF and I am grateful to what Andreas has contributed to the lives of CF-patients and their beloved ones.

Andreas could combine a human attitude and professionalism to the benefit of the patients. He helped to foster the association to an even higher reputation, both nationally and internationally. He managed to raise awareness in the public and fostered support in health-policy for the objectives of CF-patients. This again helped to bring CF into the focus of research and medical care. Thanks to his prudent financial management and his good relationship with major donors, the association could raise sufficient funds to foster research and therapy and to promote important international projects. Andreas always had an impact on patients and relatives in mind when making research and care a priority of our activities. He also encouraged patient activists in the association and co-operated with pharmaceutical companies on eye-level always keeping in mind that transparency and independence of the patient organisation must never be compromised with.

How much he cared about all people living with rare diseases is underpinned by his volunteer work as vice-president and later on as president of ACHSE, the German umbrella organisation for rare diseases.

If one day we manage to overcome CF, Dr. Reimann has contributed his share. He reminded decision-makers in Germany on their responsibility on the life of patients living with severe chronic diseases.”

Horst Mehl,
past-president and currently honorary president of Mukoviszidose e.V
"Philipp's skills, talents, and abilities are exactly what patient organizations need..."

“Philipp possesses all the many skills needed and essential for bringing together patient organizations and their KOLs into the limelight of industry! For more than 30 years, I have promoted genetic diseases and pain awareness as a health professional with a genetic diseases and chronic pain. I fully appreciate how crucial the needs for patient organizations and the mediation required by people like Philipp,  highly capable of collaborating, organizing, and following through, all essential to ensure the patient voice is heard, understood,  and brought directly to the industry. For three years, I witnessed Phillip’s commitment to patient organization collaborations. His skills, talents, and abilities are exactly what patient organizations need — and precisely what the industry requires,  to help bring  new ideas for treatment modalities into fruition.”

Susan Stephenson,
RN BSN CCRN Independent Rare Disease Pain Advocate and Consultant N. Chesterfield, VA USA
"This was truly the first patient-centric meeting I’ve ever attended, and that was very much thanks to Philipp‘s vision."

“The CDKL5 Research & Family conference, which Philipp was instrumental with in shaping the agenda, was an exceptionally great meeting! I had a chance to talk to many of the families and I know they appreciated these days and loved how much opportunity they had to participate and tell their stories and help shape the field and advance it. This was truly the first patient-centric meeting I’ve ever attended, and that was very much thanks to Philipp‘s vision.

Undisclosed pharma participant on the same conference: „You and Carol-Anne organized the best disease-focused family meeting I ever attended.  The interaction and co-collaboration amongst all constituents was extremely beneficial to everyone in attendance.  I especially appreciated hearing directly from the caregivers their needs and wants for clinical trials and new medications.”

Ana Mingorance,
Chief Development Officer LouLou Foundation, London, UK
"The DNSS experts were enthusiastic about the results and admedicum's competence"

“The Sklerodermie e.V. in connection with the scleroderma experts of the DNSS (German Network for Systemic Scleroderma) asked admedicum for support in conducting a survey among more than 1200 scleroderma patients in Germany. The aim was to investigate the extent to which scleroderma patients benefit from the infusion therapy, which is recommended but currently not refinanced and therefore difficult to obtain. The questionnaire developed by the Sklerodermie Selbsthilfe e.V. and experts in scleroderma was checked for plausibility by admedicum, supplemented, adapted, and prepared in such a way that it reached as many patients as possible in a short time, both on paper and via an online survey. admedicum did not only have considerable empathy and understood the problems and talked with us as if we would known each other already for years and let us feel that we were all on equal eye level.

The survey showed that a high percentage of patients benefit enormously from the therapy – medically and everyday life. “We finally had in our hands what we had known and experienced for years – but never in numbers and never according to different criteria could we question and evaluate.

The DNSS experts were enthusiastic about the results and admedicum’s competence and will prepare a scientific analysis on the basis of the survey, which without admedicum could not have been implemented in this way in terms of content, form or substance. This can be an important first step for the approval of the therapy and a cost assumption by the health insurance companies and thus an important step towards improved care of scleroderma patients.”

Emma Margarete Reil,
Chairman, Sklerodermie e.V.

We create value by making meaningful patient-access

We create value by making meaningful patient-access to our clients’ products and services possible. We achieve this by bringing patients and companies together at the right time and the right place. This way patients benefit by accessing innovative and truly patient oriented products and services. And companies increase their chance for return on investment.

Contact us

Chat with us today

Chat with us today to see how we can help improve your patient engagement activities. Whether you are just starting out or looking for another viewpoint on your established programs, let’s talk.



You can find us in the following locations

To hear more about our patient engagement services or discuss your challenges in more depth, get in touch. We will send you back a complete slide deck detailing more about admedicum’s expertise and schedule a time to meet.

Contact us

Latest news, events, podcasts

27. Sep 2022

Meet us at conferences and events

25. Nov 2022

“Share-of-Voice” market model 

Why digital solutions and applications will considerably reduce the significance of the “Share-of-Voice” market model in the pharmaceutical industry

20. Nov 2022

Co-creating a digital patient support solution for a rare disease

patient2care is a knowledge platform developed through co-creation with & for patients.

26. Oct 2022

How to avoid the ‘valley-of-death’ in digital clinical trial recruitment

More than one-third of clinical trial budgets is spent on recruitment and about one-third of the trials are ultimately cancelled due to insufficient participation. For me the most important negative consequence associated with the longstanding recruitment challenges is the time it will take for patients to have access to new treatments.

26. Sep 2022

Patient Engagement Networking Barcelona 2022

The debate took place as part of the networking session organized by the Spanish Association for Lysosomal Diseases and admedicum. 

15. Sep 2022

Co-creating digital health applications and digital therapeutics (DTx)

Why it matters to obtain patient insights along the digital health app and DTx development journey

13. Sep 2022

Patient-inclusion in clinical trial design recording

Ella Balasa and Dr. Andreas Reimann hosted a live discussion on Patient inclusion in clinical trial design – why it matters and how you can get started

29. Jul 2022

Patients on the Move!

“Patients on the Move!” is a brand-new podcast about Patient Engagement in Life Sciences by admedicum – PATIENT DRIVEN SOLUTIONS.

27. Jul 2022

Patient Engagement in 2030

Looking back at the Patient Engagement in 2030 symposium

01. Jul 2022

admedicum supports Lymphoma Coalition and its CAR-T project

Call for participation!